VRTX
Vertex Pharmaceuticals Incorporated
Stock
$504.73−2.01 (−0.40%)Close Oct 2, 2026
- Total assets, 2025
- $25.6B
- YoY, 2025
- +13.8%
- 5-year CAGR
- +16.9%
- 10-year CAGR
- +26.2%
Total assets
Total assets by fiscal year
| Period | Total assets | YoY |
|---|---|---|
| 2025 | $25.6B | +13.8% |
| 2024 | $22.5B | −0.9% |
| 2023 | $22.7B | +25.2% |
| 2022 | $18.2B | +35.1% |
| 2021 | $13.4B | +14.3% |
| 2020 | $11.8B | +41.3% |
| 2019 | $8.3B | +32.8% |
| 2018 | $6.3B | +76.0% |
| 2018 | $6.2B | +75.5% |
| 2017 | $3.6B | +22.8% |
| 2017 | $3.5B | +22.4% |
| 2016 | $2.9B | +15.9% |
| 2015 | $2.5B | +7.0% |
| 2014 | $2.3B | +0.7% |
| 2013 | $2.3B | −16.0% |
| 2012 | $2.8B | +25.2% |
| 2011 | $2.2B | +27.8% |
| 2010 | $1.7B | −11.8% |
| 2009 | $2.0B | — |